159 related articles for article (PubMed ID: 28972623)
1. Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA.
Kasparkova J; Kostrhunova H; Novohradsky V; Pracharova J; Curci A; Margiotta N; Natile G; Brabec V
Dalton Trans; 2017 Oct; 46(41):14139-14148. PubMed ID: 28972623
[TBL] [Abstract][Full Text] [Related]
2. Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy.
Curci A; Gandin V; Marzano C; Hoeschele JD; Natile G; Margiotta N
Inorg Chem; 2017 Jul; 56(13):7482-7493. PubMed ID: 28636387
[TBL] [Abstract][Full Text] [Related]
3. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.
Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897
[TBL] [Abstract][Full Text] [Related]
4. Combining the platinum(ii) drug candidate kiteplatin with 1,10-phenanthroline analogues.
Pages BJ; Sakoff J; Gilbert J; Zhang Y; Kelly SM; Hoeschele JD; Aldrich-Wright JR
Dalton Trans; 2018 Feb; 47(7):2156-2163. PubMed ID: 29192713
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antiproliferative activity in cancer cells and DNA interaction studies of [Pt(cis-1,3-diaminocycloalkane)Cl
Hoeschele JD; Kasparkova J; Kostrhunova H; Novakova O; Pracharova J; Pineau P; Brabec V
J Biol Inorg Chem; 2020 Sep; 25(6):913-924. PubMed ID: 32851480
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring Pt II chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand.
Kasparkova J; Suchankova T; Halamikova A; Zerzankova L; Vrana O; Margiotta N; Natile G; Brabec V
Biochem Pharmacol; 2010 Feb; 79(4):552-64. PubMed ID: 19782655
[TBL] [Abstract][Full Text] [Related]
7. The role of carrier ligands of platinum(II) anticancer complexes in the protein recognition of Pt-DNA adducts.
He Y; Yuan J; Qiao Y; Wang D; Chen W; Liu X; Chen H; Guo Z
Chem Commun (Camb); 2015 Sep; 51(74):14064-7. PubMed ID: 26248639
[TBL] [Abstract][Full Text] [Related]
8. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Copper Trafficking Proteins with the Platinum Anticancer Drug Kiteplatin.
Barbanente A; Galliani A; Iacobazzi RM; Lasorsa A; Nardella MI; Pennetta A; Margiotta N; Arnesano F
ChemMedChem; 2022 Jan; 17(1):e202100593. PubMed ID: 34727402
[TBL] [Abstract][Full Text] [Related]
10. Reactivity of kiteplatin with S-donor biomolecules and nucleotides.
Petruzzella E; Margiotta N; Natile G; Hoeschele JD
Dalton Trans; 2014 Sep; 43(34):12851-9. PubMed ID: 25051186
[TBL] [Abstract][Full Text] [Related]
11. Absence of Activation of DNA Repair Genes and Excellent Efficacy of Phosphaplatins against Human Ovarian Cancers: Implications To Treat Resistant Cancers.
Bose RN; Moghaddas S; Belkacemi L; Tripathi S; Adams NR; Majmudar P; McCall K; Dezvareh H; Nislow C
J Med Chem; 2015 Nov; 58(21):8387-401. PubMed ID: 26455832
[TBL] [Abstract][Full Text] [Related]
12. DNA fragment conformations in adducts with Kiteplatin.
Margiotta N; Petruzzella E; Platts JA; Mutter ST; Deeth RJ; Ranaldo R; Papadia P; Marzilli PA; Marzilli LG; Hoeschele JD; Natile G
Dalton Trans; 2015 Feb; 44(8):3544-56. PubMed ID: 25144401
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nuclear factor kappaB proteins-platinated DNA interactions correlates with cytotoxic effectiveness of the platinum complexes.
Brabec V; Kasparkova J; Kostrhunova H; Farrell NP
Sci Rep; 2016 Aug; 6():28474. PubMed ID: 27574114
[TBL] [Abstract][Full Text] [Related]
14. Monofunctional platinum(II) complexes with potent tumor cell growth inhibitory activity: the effect of a hydrogen-bond donor/acceptor N-heterocyclic ligand.
Margiotta N; Savino S; Gandin V; Marzano C; Natile G
ChemMedChem; 2014 Jun; 9(6):1161-8. PubMed ID: 24799414
[TBL] [Abstract][Full Text] [Related]
15. New Platinum (II) Ternary Complexes of Formamidine and Pyrophosphate: Synthesis, Characterization and DFT Calculations and
Soliman AA; Attaby FA; Alajrawy OI; Abou-Hussein AAA; Linert W
Comb Chem High Throughput Screen; 2020; 23(7):611-623. PubMed ID: 32067614
[TBL] [Abstract][Full Text] [Related]
16. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands.
Margiotta N; Savino S; Marzano C; Pacifico C; Hoeschele JD; Gandin V; Natile G
J Inorg Biochem; 2016 Jul; 160():85-93. PubMed ID: 26775068
[TBL] [Abstract][Full Text] [Related]
18. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
19. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
20. New Oxaliplatin-Pyrophosphato Analogs with Improved In Vitro Cytotoxicity.
Barbanente A; Iacobazzi RM; Azzariti A; Hoeschele JD; Denora N; Papadia P; Pacifico C; Natile G; Margiotta N
Molecules; 2021 Jun; 26(11):. PubMed ID: 34200051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
